ACTU
Actuate Therapeutics Inc
NASDAQHealthcareBiotechnologyUS
USD1.53
-0.05 (-3.16%)
Rating:C
Company Profile
CEO
Daniel Schmitt
IPO Date
2024-08-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$1.61
Prev. Close
$1.58
Day Low
$1.46
Day High
$1.63
52W Low
$1.46
52W High
$9.22
Market Cap
$0.04B
Volume
0.12M